Effect of famotidine and ranitidine on gastric secretion and emptying in the rat

The antisecretory and gastric motor effects of the new H2‐receptor antagonist famotidine (MK‐208) were compared with those of ranitidine in the rat. The Shay rat preparation (5 hr) was used for studying gastric secretion. Gastric motility was assessed by measuring gastric emptying of a liquid meal. Both compounds inhibited acid secretion in a dose‐dependent fashion. Calculated ED50 values were 0.80 and 6.84 mg·kg−1 for famotidine and ranitidine, respectively. Therefore, in this animal model, famotidine was about 9 times more potent than ranitidine. The duration of antisecretory action however, was virtually the same for both drugs. The effect of the two drugs ‐ administered at equiactive antisecretory doses ‐ on gastric emptying was different. Indeed, ranitidine significantly accelerated emptying rate, whereas famotidine was ineffective. The results of the present investigation demonstrate that famotidine is a potent and selective antisecretory compound.

[1]  C. Scarpignato,et al.  The effect of the new H2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine. , 1986, Digestion.

[2]  A. Mangel,et al.  Effects of H2-receptor antagonists upon physiological acid secretory states in animals. , 1985, The Journal of pharmacology and experimental therapeutics.

[3]  G. Porro,et al.  Famotidine in the Treatment of Gastric and Duodenal Ulceration: Overview of Clinical Experience , 1985 .

[4]  J. L. Smith,et al.  Clinical pharmacology of famotidine. , 1985, Digestion.

[5]  R. Pendleton,et al.  Studies on the H2-receptor antagonism of MK-208 in isolated rabbit gastric glands. , 1984, European journal of pharmacology.

[6]  M. Girone,et al.  Inhibition of gastric emptying and secretion by pirenzepine and atropine in rats. , 1984, European journal of pharmacology.

[7]  B. Hirschowitz Natural history of duodenal ulcer. , 1983, Gastroenterology.

[8]  M. Terai,et al.  Effect of a new potent H2-receptor antagonist 3[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2- sulfamoylpropionamidine (YM-11170) on gastric mucosal histamine-sensitive adenylate cyclase from guinea pig. , 1983, Biochemical pharmacology.

[9]  J. Modrak A computer program for multigroup comparisons , 1983 .

[10]  Y. Ishihara,et al.  Effects of antiulcer agents on healing of mepirizole-induced duodenal ulcers in rats. , 1983, Digestion.

[11]  K Van Dyke,et al.  Effect of cancer chemotherapeutic agents on the chemiluminescence of human granulocytes. , 1983, Pharmacology.

[12]  C. Scarpignato,et al.  HISTAMINE H2‐ANTAGONISTS MODIFY GASTRIC EMPTYING IN THE RAT , 1982, British journal of pharmacology.

[13]  C. F. Code Chapter Five – Histamine Receptors and Gastric Secretion , 1982 .

[14]  B. Bjerregaard,et al.  Causes and characteristics of 500 consecutive cases of jaundice. , 1981, Scandinavian journal of gastroenterology.